Switch to:
More From Other Websites
Today's Research Reports on Trending Tickers: Exelixis and Seattle Genetics Jun 27 2017
Biotech Rally Gets Second Wind As This Small Cap Nears Breaks Out Jun 26 2017
Biotech Stock With 497% Growth, Positive Trial Results Nears Buy Zone Jun 26 2017
This Drugmaker Flirts With Breakout As Some Biotechs Rally Jun 26 2017
The Reason for the Big Rise in Biotech Stocks Jun 26 2017
These 3 Stocks Are Up Over 500% in the Last 3 Years Jun 25 2017
Better Buy: Exelixis, Inc. vs. Novartis AG Jun 24 2017
Roundtable: 1 Stock I Brag About Owning Jun 23 2017
Exelixis, Inc. – Value Analysis (NASDAQ:EXEL) : June 22, 2017 Jun 22 2017
After Celgene, Regeneron Breakouts, This Biotech Stock May Be Next Jun 22 2017
Biotech Exelixis May Break Out On Cancer Drug Trial Results Jun 22 2017
Two Bullish Biotech Stocks And A Very Bearish Looking Yelp Jun 21 2017
AVEO Reaches Enrollment Target in Pivotal Tivozanib Study Jun 21 2017
Exelixis's Cabometyx Positive for First-Line Kidney Cancer Jun 20 2017
Exelixis, Inc. breached its 50 day moving average in a Bullish Manner : EXEL-US : June 20, 2017 Jun 20 2017
Today's Research Reports on Stocks to Watch: Exelixis and Westport Fuel Systems Jun 20 2017
Why Exelixis, Inc. Zoomed Higher Today Jun 19 2017
Exelixis Announces Independent Radiology Committee Review Confirms Results from CABOSUN, the Phase 2... Jun 19 2017
Key Takeaways From William Blair’s Annual Growth Stock Conference: Gilead Sciences, Inc. (GILD),... Jun 14 2017
Exelixis Initiates Cabozantinib-Tecentriq Combination Trial Jun 13 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK